Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllWhite HouseDOJECBBank of JapanFederal ReserveSEC EDGARBank of England
TopicAllenforcementfilingsmonetarypolicy

2617 items from SEC EDGAR · clear filters

  • SEC EDGARfilings
    8-K - MIMEDX GROUP, INC. (0001376339) (Filer)

    Mimedx Group, Inc. filed a Form 8-K reporting amendments to its articles of incorporation and bylaws, a change in fiscal year, and that certain matters were submitted to a vote of security holders.

  • SEC EDGARfilings
    8-K - Vaxcyte, Inc. (0001649094) (Filer)

    Vaxcyte, Inc. filed a Form 8-K on June 16, 2026, indicating that certain matters have been submitted to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - WEBSTER FINANCIAL CORP (0000801337) (Filer)

    Webster Financial Corp filed a Form 8-K on June 16, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - Opus Genetics, Inc. (0001228627) (Filer)

    Opus Genetics, Inc. filed a Form 8-K on June 16, 2026 (Accession No. 0001140361-26-025440), containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - John Marshall Bancorp, Inc. (0001710482) (Filer)

    John Marshall Bancorp, Inc. filed a Form 8-K on June 16 2026, reporting the submission of matters to a vote of security holders (Item 5.07) and providing its financial statements and related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - SkinHealth Systems Inc. (0001818093) (Filer)

    SkinHealth Systems Inc. filed a Form 8-K on June 16, 2026 indicating that certain matters have been submitted to a vote of its security holders, as required under Item 5.07.

  • SEC EDGARfilings
    8-K - ARCH CAPITAL GROUP LTD. (0000947484) (Filer)

    Arch Capital Group Ltd filed a Form 8-K on June 16, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), with the filing size of 286 KB.

  • SEC EDGARfilings
    8-K - BMO 2026-5C15 Mortgage Trust (0002128774) (Filer)

    BMO 2026-5C15 Mortgage Trust filed a Form 8-K on June 16, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001539497-26-001765.

  • SEC EDGARfilings
    8-K - Omada Health, Inc. (0001611115) (Filer)

    Omada Health, Inc. filed a Form 8-K reporting that it has submitted certain matters to a vote of its security holders.

  • SEC EDGARfilings
    8-K/A - Natera, Inc. (0001604821) (Filer)

    Natera, Inc. filed an amended Form 8-K on June 16, 2026, reporting departures, elections, appointments and compensatory arrangements for certain officers, and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Natera, Inc. (0001604821) (Filer)

    Natera, Inc. filed a Form 8-K reporting the departure and appointment of directors or officers, related compensation arrangements, submission of matters to a shareholder vote, and inclusion of financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Cytek Biosciences, Inc. (0001831915) (Filer)

    Cytek Biosciences, Inc. filed a Form 8-K on June 16, 2026, reporting that it has submitted certain matters to a vote of its security holders, as required under Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - PUMA BIOTECHNOLOGY, INC. (0001401667) (Filer)

    Puma Biotechnology, Inc. filed a Form 8-K on June 16, 2026 reporting that it has submitted certain matters to a vote of its security holders, as disclosed in Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K - Century Therapeutics, Inc. (0001850119) (Filer)

    Century Therapeutics, Inc. filed an 8-K reporting the departure of certain officers/directors, the election or appointment of new directors/officers, and disclosed the compensatory arrangements for the appointed officers.

  • SEC EDGARfilings
    8-K - AT&T INC. (0000732717) (Filer)

    AT&T filed a Form 8-K on June 16, 2026 reporting departures, elections and appointments of directors or certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGARfilings
    8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    Clover Health Investments, Corp. filed a Form 8-K reporting the departure of certain officers, the election or appointment of directors and officers, and disclosed related compensatory arrangements for those officers.

  • SEC EDGARfilings
    8-K - FiscalNote Holdings, Inc. (0001823466) (Filer)

    FiscalNote Holdings, Inc. filed a Form 8-K reporting that it has entered into a material definitive agreement and disclosed other events.

  • SEC EDGARfilings
    8-K - Everforth Inc (0000890564) (Filer)

    Everforth Inc. filed a Form 8-K on June 16, 2026, including Item 5.07 on matters submitted to a vote of security holders and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - INDEPENDENT BANK CORP (0000776901) (Filer)

    Independent Bank Corp filed a 6 MB Form 8-K on June 16, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits, under accession number 0000776901-26-000110.

  • SEC EDGARfilings
    8-K - Altimmune, Inc. (0001326190) (Filer)

    Altimmune, Inc. filed a Form 8-K with the SEC on June 16, 2026 under Item 8.01 (Other Events), accession number 0001104659-26-074575, comprising 194 KB of information.

  • SEC EDGARfilings
    8-K - Rocket Companies, Inc. (0001805284) (Filer)

    Rocket Companies, Inc. filed a Form 8-K on June 16, 2026, reporting that it has entered into a material definitive agreement, as disclosed in Item 1.01 of the filing.

  • SEC EDGARfilings
    8-K - CNB FINANCIAL CORP/PA (0000736772) (Filer)

    CNB Financial Corp filed a Form 8-K with the SEC on June 16, 2026, reporting under Item 8.01 (Other Events). The filing (Accession No. 0001193125-26-272575) is 175 KB.

  • SEC EDGARfilings
    8-K/A - Philip Morris International Inc. (0001413329) (Filer)

    Philip Morris International Inc. filed a Form 8-K/A on June 16, 2026, disclosing departures, elections, appointments and compensatory arrangements for certain officers, and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Madison Air Solutions Corp (0002098430) (Filer)

    Madison Air Solutions Corp filed a Form 8-K on June 16, 2026 reporting departures and appointments of directors or certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGARfilings
    8-K - THOR INDUSTRIES INC (0000730263) (Filer)

    Thor Industries Inc. filed a Form 8-K on June 16, 2026, reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.

  • SEC EDGARfilings
    8-K - NEXSTAR MEDIA GROUP, INC. (0001142417) (Filer)

    Nexstar Media Group, Inc. filed a Form 8-K on June 16, 2026, reporting Item 5.07 on submission of matters to a vote of security holders and Item 7.01 containing a Regulation FD disclosure.

  • SEC EDGARfilings
    8-K - Bright Mountain Media, Inc. (0001568385) (Filer)

    Bright Mountain Media, Inc. filed a Form 8-K on June 16, 2026, disclosing entry into a material definitive agreement and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - M&T BANK CORP (0000036270) (Filer)

    M&T Bank Corp filed a Form 8-K on June 16, 2026, disclosing departures, elections, appointments and compensatory arrangements for certain officers, and included its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)

    Heron Therapeutics, Inc. filed a Form 8-K on June 16, 2026 indicating that it has submitted certain matters to its security holders for a vote, as required under Item 5.07 of the filing.

  • SEC EDGARfilings
    8-K12B - Nova Minerals Ltd (0001852551) (Filer)

    Nova Minerals Ltd filed an 8-K12B reporting a material definitive agreement, a delisting notice and listing transfer, unregistered equity sales, modifications to security-holder rights, a change in control, and several director/officer appointments and departures.